OVARIO, A Phase 2 Study of Niraparib plus Bevacizumab in Advanced Ovarian Cancer (OC) Following Front-Line Platinum-Based Chemotherapy (CT) with Bevacizumab (bev): Updated Analysis

ONCOLOGY RESEARCH AND TREATMENT(2022)

引用 0|浏览16
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要